Rheumatoid arthritis: Disease or syndrome?

Open Access Rheumatology: Research and Reviews

Volumn 1, Issue 1, 2009, Pages 179-192

  Stanich, Jessica A ^a   Carter, John D ^b   Whittum Hudson, Judith ^a   Hudson, Alan P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Rheumatoid arthritis pathogenesis etiologic studies genetic background

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HLA DR ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RHEUMATOID FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CLINICAL ASSESSMENT; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; ERYTHROCYTE SEDIMENTATION RATE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; INFECTION; PATHOGENESIS; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; VIRUS INFECTION;

EID: 77953386236     PISSN: None     EISSN: 1179156X     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Landre-Beauvais AJ. The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800. Joint Bone Spine. 2001;68:130-143.
2. Dequeker J, Rico H. Rheumatoid arthritis-like deformities in an early 16th-century painting of the Flemish-Dutch school. JAMA. 1992;268: 249-251.
3. Sangha O. Epidemiology of rheumatic diseases. Rheumatology (Oxford). 2000;39(Suppl 2):3-12.
4. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15-25.
5. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001;27:269-281.
6. Ward MM, Javitz HS, Yelin EH. The direct cost of rheumatoid arthritis. Value Health. 2000;3:243-252.
7. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis - are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol. 2003;136:1-8.
8. Guerne PA, Weisman MH. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med. 1992;93:451-460.
9. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62: 722-727.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
11. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci. 2008;1143:268-285.
12. Lee AN, Beck CE, Hall M. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Clin Lab Sci. 2008;21:15-18.
13. Renaudineau Y, Jamin C, Saraux A, Youinou P. Rheumatoid factor on a daily basis. Autoimmunity. 2005;38:11-16.
14. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford). 2008;47:399-402.
15. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):S265-S272.
16. Iikuni N, Nakajima A, Inoue E, et al. What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology (Oxford). 2007;46:846-848.
17. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults. Vital Health Stat. 1966;11:1-43.
18. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.
19. Bridges SL Jr, Hughes LB, Mikuls TR, et al. Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol. 2003;21:S138-S145.
20. Escalante A, del Rincon I. Epidemiology and impact of rheumatic disorders in the United States Hispanic population. Curr Opin Rheumatol. 2001;13:104-110.
21. Iwanaga T, Shikichi M, Kitamura H, Yanase H, Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Arch Histol Cytol. 2000;63:17-31.
22. Raza K, Scheel-Toellner D, Lee CY, et al. Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthritis Res Ther. 2006;8:R120.
23. Ospelt C, Gay S. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol. 2008;22:239-252.
24. Weyand CM, Bryl E, Goronzy JJ. The role of T cells in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 2000;48:429-435.
25. Taylor PC. Antibody therapy for rheumatoid arthritis. Curr Opin Pharmacol. 2003;3:323-328.
26. So T, Lee SW, Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol. 2006;83:1-11.
27. Kim EY, Moudgil KD. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol Lett. 2008;120:1-5.
28. Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci. 2008;13:5094-5107.
29. Ye J. Regulation of PPARgamma function by TNF-alpha. Biochem Biophys Res Commun. 2008;374:405-408.
30. Wallis RS. Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis. 2009;22:403-409.
31. Morko J, Kiviranta R, Mulari MT, et al. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro. Bone. 2009;44:717-728.
32. Kreuwel HT, Sherman LA. The T-cell repertoire available for recognition of self-antigens. Curr Opin Immunol. 2001;13:639-643.
33. Prakken BJ, Carson DA, Albani S. T cell repertoire formation and molecular mimicry in rheumatoid arthritis. Curr Dir Autoimmun. 2001; 3:51-63.
34. Newkirk MM. Rheumatoid factors: what do they tell us? J Rheumatol. 2002;29:2034-2040.
35. Nowak U, Gill K, Skamene E, Newkirk MM. Rheumatoid factor induction in murine models of liver injury. Clin Exp Immunol. 2007;147: 324-329.
36. De Rycke L, Peene I, Hoffman IE, et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extraarticular manifestations. Ann Rheum Dis. 2004;63:1587-1593.
37. Kinloch A, Lundberg K, Wait R, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 2008;58:2287-2295.
38. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006;116:961-973.
39. Kidd BA, Ho PP, Sharpe O, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther. 2008;10:R119.
40. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177-4184.
41. Mewar D, Wilson AG. Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother. 2006;60:648-655.
42. Andersson AK, Li C, Brennan FM. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther. 2008;10:204.
43. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647-1656.
44. Lan RY, Ansari AA, Lian ZX, Gershwin ME. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev. 2005; 4:351-363.
45. Kirkham BW, Lassere MN, Edmonds JP, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 2006;54:1122-1131.
46. Lard LR, van Gaalen FA, Schonkeren JJ, et al. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis Rheum. 2003;48:1841-1848.
47. Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol. 2009;4:417-434.
48. Pongratz G, Straub RH. B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system? Immunol Res. 2008;40:148-163.
49. O'Neill SK, Glant TT, Finnegan A. The role of B cells in animal models of rheumatoid arthritis. Front Biosci. 2007;12:1722-1736.
50. Harris DP, Goodrich S, Gerth AJ, Peng SL, Lund FE. Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor. J Immunol. 2005;174:6781-6790.
51. Silman AJ. Rheumatoid arthritis and infection: a population approach. Ann Rheum Dis. 1989;48:707-710.
52. Ebringer A. Rheumatoid arthritis as an infectious disease. BMJ. 1991; 303:524.
53. Dixon B. Bacteria and arthritis. BMJ. 1990;301:1043.
54. Ford DK. One syndrome - many infectious agents. J Rheumatol. 1987; 14:650-652.
55. Ford DK, Tingle AJ. Lymphocytes from site of disease indicate probable microbiological etiology of "infective-immune" diseases such as rheumatoid arthritis. Infect Agents Dis. 1996;5:223-230.
56. Ford DK. Understanding rheumatoid arthritis. J Rheumatol. 1997;24: 1464-1466.
57. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883-896.
58. Rashid T, Ebringer A. Rheumatoid arthritis is linked to Proteus - the evidence. Clin Rheumatol. 2007;26:1036-1043.
59. Kobayashi S, Momohara S, Kamatani N, Okamoto H. Molecular aspects of rheumatoid arthritis: role of environmental factors. FEBS J. 2008;275:4456-4462.
60. Weyand CM, Goronzy JJ. The molecular basis of rheumatoid arthritis. J Mol Med. 1997;75:772-785.
61. Munz C, Lunemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009;9:246-258.
62. Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 2003;11:101-105.
63. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cellmediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695-705.
64. Davies JM. Introduction: Epitope mimicry as a component cause of autoimmune disease. Cell Mol Life Sci. 2000;57:523-526.
65. Kouri T, Petersen J, Rhodes G, et al. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol. 1990;17: 1442-1449.
66. Brand A, Griffiths DJ, Herve C, Mallon E, Venables PJ. Human retrovirus-5 in rheumatic disease. J Autoimmun. 1999;13:149-154.
67. Krause A, Kamradt T, Burmester GR. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol. 1996;8:203-209.
68. Takei M, Mitamura K, Fujiwara S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol. 1997;9: 739-743.
69. Edinger JW, Bonneville M, Scotet E, Houssaint E, Schumacher HR, Posnett DN. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol. 1999;162:3694-3701.
70. Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, Sundqvist VA. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol. 1998;25:623-628.
71. Gaudin P, Moutet F, Tuke PW, Garson JA. Absence of human retrovirus 5 in French patients with rheumatoid arthritis: comment on the article by Griffiths, et al. Arthritis Rheum. 1999;42:2492-2494.
72. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and crossreact with bacterial enolase. Arthritis Rheum. 2008;58:3009-3019.
73. Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today. 1996;17: 466-470.
74. Toussirot E, Roudier J. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine. 2007;74:418-426.
75. Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol. 1998;10:187-200.
76. Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum. 1994;24:19-28.
77. van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther. 2008;10:205.
78. Li Y, Begovich AB. Unraveling the genetics of complex diseases: Susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol. 2009;13:13.
79. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci U S A. 2007;104: 8685-8690.
80. Singal DP, Li J, Zhu Y. Genetic basis for rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 1999;47:307-311.
81. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205-1213.
82. Rak JM, Maestroni L, Balandraud N, et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 2009;60:73-80.
83. Popa C, Leandro MJ, Cambridge G, Edwards JC. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs. Rheumatology (Oxford). 2007;46:626-630.
84. Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77:1044-1060.
85. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun. 2009;32:158-162.
86. Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet. 2005;50:264-266.
87. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet. 2001;69:936-950.
88. Choi SJ, Rho YH, Ji JD, Song GG, Lee YH. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford). 2006;45:166-170.
89. Vittecoq O, Lequerre T, Goeb V, Le Loet X, Abdesselam TA, Klemmer N. Smoking and inflammatory diseases. Best Pract Res Clin Rheumatol. 2008;22:923-935.
90. Kallberg H, Jacobsen S, Bengtsson C, et al. Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis. 2009;68: 222-227.
91. Heliovaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20:1830-1835.
92. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62:835-841.
93. Costenbader KH, Manson JE. Do female hormones affect the onset or severity of rheumatoid arthritis? Arthritis Rheum. 2008;59:299-301.
94. Mattey DL, Dawes PT, Clarke S, et al. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum. 2002;47:403-407.
95. Lee HS, Irigoyen P, Kern M, et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 2007;56:1745-1753.
96. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38-46.
97. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, et al. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Arthritis Rheum. 2007;56:2913-2918.
98. Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68:201-208.
99. Rashid T, Ebringer A. Rheumatoid arthritis in smokers could be linked to Proteus urinary tract infections. Med Hypotheses. 2008;70: 975-980.
100. Nalbandian G, Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res. 2005;31:91-106.
101. Spector TD, Roman E, Silman AJ. The pill, parity, and rheumatoid arthritis. Arthritis Rheum. 1990;33:782-789.
102. Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Berglund G, Turesson C. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis. 2009;68:526-530.
103. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum. 2004; 50:3458-3467.
104. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am. 1997;23:195-212.
105. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci. 1998;840:45-50.
106. Kovats S, Carreras E. Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cell Immunol. 2008;252: 81-90.
107. + CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol. 2004;172: 1426-1436.
108. Walitt B, Pettinger M, Weinstein A, et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum. 2008;59:302-310.
109. Walitt BT, Constantinescu F, Katz JD, et al. Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative. J Rheumatol. 2008;35:811-818.
110. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun Rev. 2003;2:133-139.
111. Inman RD, Whittum-Hudson JA, Schumacher HR, Hudson AP. Chlamydia and associated arthritis. Curr Opin Rheumatol. 2000;12: 254-262.
112. Villareal C, Whittum-Hudson JA, Hudson AP. Persistent Chlamydiae and chronic arthritis. Arthritis Res. 2002;4:5-9.
113. Whittum-Hudson JA, Gerard HC, Schumacher HR, Hudson AP. Pathogenesis of Chlamydia-associated arthritis. In: Bavoil P, Wyrick P, editors. Chlamydia - Genomics and Pathogenesis. Oxford, UK: Horizon Bioscience, Inc; 2007:475-504.
114. Gerard HC, Whittum-Hudson JA, Carter JD, Hudson AP. Molecular biology of infectious agents in chronic arthritis. In: Espinoza L, editor. Rheumatic Disease Clinics of North America. Philadelphia PA: Elsevier/Saunders; 2009:1-19.